Authors: GILES FJ KUSUANCO D LYNOTT A SHAH PM WANG LX SUPANDIMAN I POOVALINGAM V RANA F AZIZ F CHEN YC DUTOIT PJ JANUSZEWICZ H TEE GY WOLF M SUMANTRI R ALOMARI K TIAN D BEZWODA WR ABDI E GONZAGA M FAHED F FOURIE LS RUFF P POOL R KIM HC PARIKH PM KIM KY HO BS TAN P LEE SN TIEN SL WIJONO A LOBERIZA S LEE GH KIM SY HO CH BAYLON H AHN MJ THOMAS M WOLF M TIEN HF AYDOGDU I TAM J LIM SW CAVILEZ A

Citation: Fj. Giles et al., PROGNOSTIC FACTORS IN PATIENTS WITH PH-PHASE CHRONIC MYELOGENOUS LEUKEMIA (CML) ENROLLED IN THE INTERNATIONAL ONCOLOGY STUDY-GROUP (IOSG) CML1 STUDY( EARLY CHRONIC), British Journal of Haematology, 102(1), 1998, pp. 187-187

Authors: BELLER E TATTERSALL M LUMLEY T LEVI J DALLEY D OLVER I PAGE J ABDI E WYNNE C FRIEDLANDER M BOADLE D WHEELER H MARGRIE S SIMES RJ

Citation: E. Beller et al., IMPROVED QUALITY-OF-LIFE WITH MEGESTROL-ACETATE IN PATIENTS WITH ENDOCRINE-INSENSITIVE ADVANCED CANCER - A RANDOMIZED PLACEBO-CONTROLLED TRIAL, Annals of oncology, 8(3), 1997, pp. 277-283

Authors: MILANIAN I GHODS AJ MAHMOUDIAN M PROUSHANINIA F GASHTI HN ABDI E ABBASI M

Citation: I. Milanian et al., STUDY OF CIRCADIAN VARIATION OF CYCLOSPORINE PHARMACOKINETICS, Transplantation proceedings, 29(7), 1997, pp. 2930-2931